Yared Hailemichael
Yared Hailemichael
Verified email at
Cited by
Cited by
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Y Hailemichael, Z Dai, N Jaffarzad, Y Ye, MA Medina, XF Huang, ...
Nature medicine 19 (4), 465-472, 2013
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
H Qin, B Lerman, I Sakamaki, G Wei, SC Cha, SS Rao, J Qian, ...
Nature medicine 20 (6), 676-681, 2014
Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release
P Jayaraman, F Parikh, E Lopez-Rivera, Y Hailemichael, A Clark, G Ma, ...
The Journal of Immunology 188 (11), 5365-5376, 2012
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
M Sharma, H Khong, F Fa’ak, SE Bentebibel, LME Janssen, BC Chesson, ...
Nature communications 11 (1), 661, 2020
IFN-α enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity
AG Sikora, N Jaffarzad, Y Hailemichael, A Gelbard, SW Stonier, ...
The Journal of Immunology 182 (12), 7398-7407, 2009
Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy
AG Sikora, A Gelbard, MA Davies, D Sano, S Ekmekcioglu, J Kwon, ...
Clinical cancer research 16 (6), 1834-1844, 2010
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Y Hailemichael, DH Johnson, N Abdel-Wahab, WC Foo, SE Bentebibel, ...
Cancer Cell 40 (5), 509-523. e6, 2022
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy
Y Hailemichael, A Woods, T Fu, Q He, MC Nielsen, F Hasan, J Roszik, ...
The Journal of clinical investigation 128 (4), 1338-1354, 2018
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
M Singh, C Vianden, MJ Cantwell, Z Dai, Z Xiao, M Sharma, H Khong, ...
Nature communications 8 (1), 1447, 2017
Anti-tumor activity mediated by CpG: the route of administration is critical
Y Lou, C Liu, G Lize, W Peng, C Xu, Y Ye, BA Rabinovich, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 34 (3), 279, 2011
Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression
HJ Dalton, S Pradeep, M McGuire, Y Hailemichael, S Ma, Y Lyons, ...
Clinical Cancer Research 23 (22), 7034-7046, 2017
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma
X Zhang, HC Lee, F Shirazi, V Baladandayuthapani, H Lin, I Kuiatse, ...
Leukemia 32 (10), 2224-2239, 2018
The glutaminase inhibitor CB-839 (telaglenastat) enhances the antimelanoma activity of T-cell–mediated immunotherapies
S Varghese, S Pramanik, LJ Williams, HR Hodges, CW Hudgens, ...
Molecular cancer therapeutics 20 (3), 500-511, 2021
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter
K Ritthipichai, CL Haymaker, M Martinez, A Aschenbrenner, X Yi, ...
Clinical Cancer Research 23 (20), 6151-6164, 2017
Inhibition of p-STAT3 enhances IFN-α efficacy against metastatic melanoma in a murine model
LY Kong, A Gelbard, J Wei, C Reina-Ortiz, Y Wang, EC Yang, ...
Clinical Cancer Research 16 (9), 2550-2561, 2010
Host‐finding behavior, host acceptance, and host suitability of the parasite Xanthopimpla stemmator
Y Hailemichael, JW Smith Jr, RN Wiedenmann
Entomologia experimentalis et applicata 71 (2), 155-166, 1994
Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways
SM Anthony, ME Howard, Y Hailemichael, WW Overwijk, KS Schluns
PLoS One 10 (3), e0120274, 2015
Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard
Y Hailemichael, WW Overwijk
Oncoimmunology 2 (7), e24743, 2013
Mouse model for Pre‐Clinical study of human cancer immunotherapy
Z Ya, Y Hailemichael, W Overwijk, NP Restifo
Current protocols in immunology 108 (1), 20.1. 1-20.1. 43, 2015
Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination
Y Hailemichael, WW Overwijk
The international journal of biochemistry & cell biology 53, 46-50, 2014
The system can't perform the operation now. Try again later.
Articles 1–20